Surrozen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Surrozen and other ETFs, options, and stocks.

About SRZN

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues.

CEO

Craig C. Parker

CEOCraig C. Parker

Employees

Employees42

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees42

SRZN Key Statistics

Market cap

37.67M

Market cap37.67M

Price-Earnings ratio

-0.68

Price-Earnings ratio-0.68

Dividend yield

—

Dividend yield—

Average volume

5.44K

Average volume5.44K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$18.17

52 Week high$18.17

52 Week low

$6.00

52 Week low$6.00

Surrozen

Why Robinhood?

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Show more

SRZN Key Statistics

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues.